Cerity Partners’s Adient ADNT Stock Holding History
Bought
Maintained
Sold
Other funds holding ADNT
HHAM
Cerity Partners's ADNT Position: Q2 2026 in Review
Cerity Partners reduced its Adient (ADNT) stake by 11% in Q2 2026, selling an estimated $67.8K and leaving 25,817 shares worth $475K. The position accounts for ﹤0.01% of the portfolio, ranked #2464.
Cerity Partners first reported a position in ADNT in Q1 2024 and has held it in 7 quarters since. The position peaked at $910K in Q3 2025. 313 funds tracked by Wall St. Rank hold ADNT as of Q2 2026.
- Cerity Partners held 25,817 shares of Adient worth $475K as of Q2 2026.
- Cerity Partners sold 3,172 Adient shares in Q2 2026, an estimated $67.8K.
- Adient made up ﹤0.01% of Cerity Partners's portfolio in Q2 2026, its #2464 holding.
- Cerity Partners first reported a position in Adient in Q1 2024 and has held it in 7 quarters since.
- Cerity Partners's Adient position peaked at $910K in Q3 2025.
- 313 funds tracked by Wall St. Rank held Adient as of Q2 2026.
Based on Cerity Partners's 13F filing for Q2 2026, filed 14 Aug 2026.